Angélique Gougelet

Summary

Affiliation: Institut Paoli-Calmettes
Country: France

Publications

  1. ncbi Lymphoma and myeloma cell resistance to cytotoxic agents and ionizing radiations is not affected by exposure to anti-IL-6 antibody
    Angélique Gougelet
    Unité INSERM U590 équipe Cytokines et Cancer, Centre Leon Berard, Lyon, France
    PLoS ONE 4:e8026. 2009
  2. ncbi Micro-RNA profiles in osteosarcoma as a predictive tool for ifosfamide response
    Angélique Gougelet
    Unité INSERM U590 équipe Cytokines et Cancer, Centre Leon Berard, 69373 Lyon Cedex 08, France
    Int J Cancer 129:680-90. 2011
  3. ncbi miRNA Profiling: How to Bypass the Current Difficulties in the Diagnosis and Treatment of Sarcomas
    Angélique Gougelet
    Unité INSERM U590 équipe Cytokines et Cancer, Centre Leon Berard, 28 rue Laennec, 69373 Lyon Cedex 08, France
    Sarcoma 2011:460650. 2011

Detail Information

Publications3

  1. ncbi Lymphoma and myeloma cell resistance to cytotoxic agents and ionizing radiations is not affected by exposure to anti-IL-6 antibody
    Angélique Gougelet
    Unité INSERM U590 équipe Cytokines et Cancer, Centre Leon Berard, Lyon, France
    PLoS ONE 4:e8026. 2009
    ..We investigated whether monoclonal antibodies directed against IL-6 may enable to reverse resistance of cancer cell lines...
  2. ncbi Micro-RNA profiles in osteosarcoma as a predictive tool for ifosfamide response
    Angélique Gougelet
    Unité INSERM U590 équipe Cytokines et Cancer, Centre Leon Berard, 69373 Lyon Cedex 08, France
    Int J Cancer 129:680-90. 2011
    ....
  3. ncbi miRNA Profiling: How to Bypass the Current Difficulties in the Diagnosis and Treatment of Sarcomas
    Angélique Gougelet
    Unité INSERM U590 équipe Cytokines et Cancer, Centre Leon Berard, 28 rue Laennec, 69373 Lyon Cedex 08, France
    Sarcoma 2011:460650. 2011
    ..As highlighted by these results, miRNA profiling emerges as a potent molecular diagnostic tool for complex karyotype sarcomas...